Harry Dietz

Harry Dietz

Director/Board Member at GSK PLC

Net worth: 88 667 $ as of 2024-03-30

66 year
Commercial Services
Consumer Services
Health Technology

Profile

Harry C.
Dietz
is the founder of Blade Therapeutics, Inc. founded in 2015.
Currently, he is an Independent Non-Executive Director at GSK Plc since 2022.
Previously, he served as the President of the American Society of Human Genetics.
Dr. Dietz's education includes an undergraduate degree from Duke University and a doctorate from SUNY Upstate Medical University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-04-11 4,108 ( 0.00% ) 88 667 $ 2024-03-30

Harry Dietz active positions

CompaniesPositionStart
GSK PLC Director/Board Member 2021-12-31
All active positions of Harry Dietz

Former positions of Harry Dietz

CompaniesPositionEnd
President -
Founder -
See the detail of Harry Dietz's experience

Training of Harry Dietz

Duke University Undergraduate Degree
SUNY Upstate Medical University Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Harry Dietz's experience

Connections

47

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
GSK PLC

Health Technology

Private companies2

Commercial Services

Commercial Services

See company connections